share_log
Reuters ·  Jul 19 10:02
Shenzhen Chipscreen Biosciences: Treatment of Type 2 Diabetes With Chiglitazar Combined With Metformin Approved for Listing by Nmpa
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment